InvestorsHub Logo

vinmantoo

11/22/22 3:27 PM

#2339 RE: Jake2234 #2338

They have an exorbitant spend and no indication that this drug even works. A very tricky clinical development path.



Two lies in one post! Impressive. There is strong evidence that EDP-235 robustly inhibits Covid and the amount of money needed to get it through phase 2 trials isn't very high.

I notice your alias was just made today and that was nonsensical post is your only post. Short alert, short alert.
Bullish
Bullish